Radiometal-labeled anti-VCAM-1 nanobodies as molecular tracers for atherosclerosis – impact of radiochemistry on pharmacokinetics
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Radiometal-labeled anti-VCAM-1 nanobodies as molecular tracers for atherosclerosis – impact of radiochemistry on pharmacokinetics
Authors
Keywords
-
Journal
BIOLOGICAL CHEMISTRY
Volume -, Issue -, Pages -
Publisher
Walter de Gruyter GmbH
Online
2018-09-21
DOI
10.1515/hsz-2018-0330
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New methods to image unstable atherosclerotic plaques
- (2018) Jack P.M. Andrews et al. ATHEROSCLEROSIS
- Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology
- (2018) Ahmet Krasniqi et al. JOURNAL OF NUCLEAR MEDICINE
- Evaluation of Antiatherogenic Properties of Ezetimibe Using 3 H-Labeled Low-Density-Lipoprotein Cholesterol and 99m Tc-cAbVCAM1–5 SPECT in ApoE −/− Mice Fed the Paigen Diet
- (2017) Laurent S. Dumas et al. JOURNAL OF NUCLEAR MEDICINE
- Chemically-defined camelid antibody bioconjugate for the magnetic resonance imaging of Alzheimer's disease
- (2017) Matthias Vandesquille et al. mAbs
- Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma
- (2017) Ahmet Krasniqi et al. MOLECULAR CANCER THERAPEUTICS
- Evaluation of [99mTc]Radiolabeled Macrophage Mannose Receptor-Specific Nanobodies for Targeting of Atherosclerotic Lesions in Mice
- (2017) Gezim Bala et al. MOLECULAR IMAGING AND BIOLOGY
- Translating Molecular Imaging of the Vulnerable Plaque—a Vulnerable Project?
- (2017) Gezim Bala et al. MOLECULAR IMAGING AND BIOLOGY
- Improved Debulking of Peritoneal Tumor Implants by Near-Infrared Fluorescent Nanobody Image Guidance in an Experimental Mouse Model
- (2017) Pieterjan Debie et al. MOLECULAR IMAGING AND BIOLOGY
- Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided Surgery
- (2017) Pieterjan Debie et al. MOLECULAR PHARMACEUTICS
- Technical Aspects of Cardiac PET Imaging and Recent Advances
- (2016) Guido Germano et al. CARDIOLOGY CLINICS
- Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities
- (2016) Sam Massa et al. Contrast Media & Molecular Imaging
- Nanobodies as therapeutics: big opportunities for small antibodies
- (2016) Sophie Steeland et al. DRUG DISCOVERY TODAY
- Variation of Specific Activities of 68Ga-Aquibeprin and 68Ga-Avebetrin Enables Selective PET Imaging of Different Expression Levels of Integrins 5 1 and v 3
- (2016) J. Notni et al. JOURNAL OF NUCLEAR MEDICINE
- Targeting of vascular cell adhesion molecule-1 by18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques
- (2016) Gezim Bala et al. European Heart Journal-Cardiovascular Imaging
- Radiometals: towards a new success story in nuclear imaging?
- (2015) David Brasse et al. DALTON TRANSACTIONS
- Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma
- (2015) M. Keyaerts et al. JOURNAL OF NUCLEAR MEDICINE
- PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments
- (2015) A. Blykers et al. JOURNAL OF NUCLEAR MEDICINE
- 99mTc-cAbVCAM1-5 Imaging Is a Sensitive and Reproducible Tool for the Detection of Inflamed Atherosclerotic Lesions in Mice
- (2014) A. Broisat et al. JOURNAL OF NUCLEAR MEDICINE
- Functional knock down of VCAM1 in mice mediated by endoplasmatic reticulum retained intrabodies
- (2014) Andrea LJ Marschall et al. mAbs
- PET imaging of inflammation in atherosclerosis
- (2014) Jason M. Tarkin et al. Nature Reviews Cardiology
- Nanobody: The “Magic Bullet” for Molecular Imaging?
- (2014) Rubel Chakravarty et al. Theranostics
- Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount
- (2014) Mark W. Konijnenberg et al. EJNMMI Research
- Matching chelators to radiometals for radiopharmaceuticals
- (2013) Eric W. Price et al. CHEMICAL SOCIETY REVIEWS
- Synthesis, Preclinical Validation, Dosimetry, and Toxicity of 68Ga-NOTA-Anti-HER2 Nanobodies for iPET Imaging of HER2 Receptor Expression in Cancer
- (2013) C. Xavier et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular Imaging of Atherosclerosis for Improving Diagnostic and Therapeutic Development
- (2012) Thibaut Quillard et al. CIRCULATION RESEARCH
- Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions
- (2012) Alexis Broisat et al. CIRCULATION RESEARCH
- Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer
- (2011) Ilse Vaneycken et al. FASEB JOURNAL
- Nanobody-coupled microbubbles as novel molecular tracer
- (2011) Sophie Hernot et al. JOURNAL OF CONTROLLED RELEASE
- Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels
- (2010) Vladimir Tolmachev et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Regional quantitative analysis of small animal myocardial sympathetic innervation and initial application in streptozotocin induced diabetes
- (2009) Lode R. Goethals et al. Contrast Media & Molecular Imaging
- Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected tracer amount
- (2009) Vladimir Tolmachev et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now